Henson, C.; Clayburgh, D.; Lee, A.; Wong, D.; Kudrimoti, M.; Lee, S.; Kalman, N.; Rao, K.; Sohn, K.Y.; Crawford, J.;
et al. A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck. Cancers 2025, 17, 1663.
https://doi.org/10.3390/cancers17101663
AMA Style
Henson C, Clayburgh D, Lee A, Wong D, Kudrimoti M, Lee S, Kalman N, Rao K, Sohn KY, Crawford J,
et al. A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck. Cancers. 2025; 17(10):1663.
https://doi.org/10.3390/cancers17101663
Chicago/Turabian Style
Henson, Christina, Daniel Clayburgh, Arielle Lee, Deborah Wong, Mahesh Kudrimoti, Steve Lee, Noah Kalman, Krishna Rao, Ki Young Sohn, Jeffrey Crawford,
and et al. 2025. "A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck" Cancers 17, no. 10: 1663.
https://doi.org/10.3390/cancers17101663
APA Style
Henson, C., Clayburgh, D., Lee, A., Wong, D., Kudrimoti, M., Lee, S., Kalman, N., Rao, K., Sohn, K. Y., Crawford, J., Villa, A., & Sonis, S.
(2025). A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck. Cancers, 17(10), 1663.
https://doi.org/10.3390/cancers17101663